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Abstract: This comprehensive review deals with the synthesis of 1-azafagomine, analogues, and 
derivatives having the Diels-Alder cycloaddition as the key step. Most of the compounds referred are 
racemic or have been resolved by lipase transesterification. There are two asymmetric cycloadditions 
leading to 1-azafagomine or to an analogue. In one case both enantiomers of 1-azafagomine were 
prepared together with a pair of derivatives. The study comprises glycosidase inhibition studies of the 
target compounds to a set of glycosidic enzymes, and evidenced molecular features that enhance or 
diminish their activity as glycosidase inhibitors. 
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Introduction 
 
Glycosidases are crucial enzymes in all living organisms because they control many biological 
processes. Potent and selective inhibition of these enzymes is a very important topic that deals with 
finding the right chemical entities, mainly entrusted to synthetic chemists. Azasugars are major targets 
as glycosidase inhibitors due to their ability to mimic the transition state of saccharides in the enzymes. 
Two azasugars are currently being used in clinics: Miglitol against diabetes type II from Gliset
®
, and 
Miglustat against Gaucher disease from Zavesca
®
. Many other azasugars had showed to be active 
against diabetes [1], cancer [2], hepatitis [3], Gaucher’s disease [3], AIDS [4,5] and influenza [6]. In 
some cases the target azasugars reached advanced clinical trials, as did D-swainsonine that passed till 
clinical trial phase II [7], but for one or another undesirable secondary effects they have failed to be 
introduced as pharmaceuticals. Figure 1 shows the five groups of natural azasugars known. This brief 
review deals only with synthetic piperidine and indolizidine analogues, containing a N-N unit 
incorporated in the molecules, in which the crucial process in its synthesis is a Diels-Alder 
cycloaddition.  
 
 
 
 
Figure 1- Natural azasugar groups. 
 
Azasugars are able to disguise sugars because the cleavage of the anomeric group develops a positive 
charge that can be stabilized either by oxygen or nitrogen atoms, attached to the anomeric carbon. 
Figure 2 shows the developing positive charges on the transition state of glucosides in glucosidases 
active sites. The cleavage of the anomeric oxygen group develops a positive charge at the anomeric 
carbon (A), and the resonance effect creates a second transition state (B). Which of these transition 
states seems more important it depends on the enzyme, although it is likely that most enzymes have a 
component of each [8-10]. 
H
NHO OH
OHHO
OH
N
OH
H OH
OH N
OHHO H
OH
OH
N
H
OH
OH
NH
HO
HO
HO
nortropanepirrolidinepirrolizidineindolizidinepiperidine
 3 
 
 
Figure 2- Two possible transition states of a D-glucose unit in a saccharide. 
 
It had been explained that the stereoelectronic effect that assists the -cleavage is due to the anti-
periplanar disposition of the axial electron pair at the glucopyranose oxygen atom to give type B 
transition state, with the positive developing charge at the oxygen. On the other hand, the -cleavage 
has to occur with no stereoelectronic assistance, giving transition state type A with the positive charge 
developing at the anomeric carbon atom [11]. (Figure 2) As a consequence glucose analogues that 
develop a positive charge at the oxygen/nitrogen atoms will be -inhibitors, and those that develop a 
positive charge on the anomeric carbon will be -inhibitors.  
 
2. Synthesis of racemic 1-azafagomine, and analogues  
()-1-Azafagomine (1) potently inhibits yeast -glucosidase and almond -glucosidase with very low 
Ki values as will be presented ahead. This means that there is a close connection in the ability of 1-
azafagomine to accept a proton at the active site of the enzyme and the transition states A and B.  In 
fact the mixture of the hydrazonium ions clearly resemble transition states A and B. (Figure 3) On this 
basis is to be expected that they will fit well in the active site of - and -glucosidases, explaining the 
potential of such compounds over these enzymes. 
 
 
Figure 3- Structural resemblance between glucose transition states A and B with the two hydrazonium 
ions of protonated 1-azafagomine. 
  
 
2.1 Synthesis of 1-azafagomine, and monocyclic analogues  
Racemic 1-azafagomine ()-1 was obtained through a synthetic sequence based on a Diels-Alder 
cycloaddition between achiral materials: 2,4-pentadien-1-ol (2) and 4-phenyl-1,2,4-triazole-3,5-dione 
(PTAD, 3). The racemic cycloadduct 4 was epoxidized with trifluoromethyl(methyl)dioxirane 
generated in situ to furnish a 3:1 ratio of isomers, from which the major epoxide, 5, was isolated in 
62 % yield. The hydrolysis of epoxide 5 under perchloric acid afforded triol 6 in 73 % with a high 
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degree of stereoselectivity. Treatment of 6 with hydrazine at 100 ºC gave finally compound  ()-1 in 
84 % yield [11]. (Scheme 1) 
 
Scheme 1- Synthesis of racemic 1-azafagomine 1. 
 
A high biological activity was found in racemic 1-azafagomine, inhibiting both - -glucosidases. 
The almond -glucosidase inhibition is demonstrated by the Ki = 0.65 M at pH=6.8, but curiously, the 
results are not much different with pH ranging from 5.0 to 7.5: at pH = 5.0, Ki = 0.76 M, and pH = 7.5, 
Ki = 1.09 M. To explain the independence of the inhibition potential of 1-azafagomine (1) to the 
medium pH, compound (±)-1 was protonated with aqueous acidic solution and titrated with NaOH; the 
pKa was revealed to be 3.9. Hydrazine is very weak base, largely unprotonated even at pH=5.0. This 
means that the unprotonated 1-azafagomine is the enzyme substrate even at pH=5. 1-Azafagomine is 
also a potent inhibitor of yeast -glucosidase Ki= 3.9 M at pH= 6.8 [11]. Isomaltase from backer’s 
yeast and phosphorylase A are too highly inhibited by 1-azafagomine with Ki = 1.06 M and IC50 = 
13.5 M respectively. Other glycosidases were tested including - / -galactosidases and -
mannosidases, but the results were very poor. Interestingly compound 1 combines the strong -
inhibition of deoxynojirimycine (DNJ) with the strong -inhibition of isofagomine showing that 1-
azafagomine is able to mimic both the transition state A and B, and can be considered a hybrid of those 
azasugars. But, on the contrary, deoxynojirimycine and isofagomine are highly dependent of the pH 
experiment, which agrees with their much higher basicity. (See Table 1) 
Pyridazines 7 and 8 do not have the configuration of any natural sugar, but they were moderately 
competitive inhibitors of -glucosidase and -mannosidase; compound 7 is in some extent also a 
moderate inhibitor of -galactosidase. Compound 7 was obtained in 79 % yield by osmilation of 
compound 4; compound 8 was obtained in 55 % overall yield, following the steps described in scheme 
1, but using piperylene as the diene. (Figure 4) 
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Figure 4- Structures of compounds (±)-7 and (±)-8. 
 
Using piperylene or 1,3-butadiene as dienes and PTAD as dienophile, were obtained cycloadducts 9a 
and 9b [12]. The synthetic process includes first the synthesis of the oxirane with 
trifluoromethyl(methyl)dioxirane which was then treated with acetic anhydride in acetic acid in the 
presence of trifluoroboro etherate to yield compounds 10a (80.8 %) and 10b as 6 (trans) : 1 (cis) 
mixture of isomers (80.9 %). The diacetates were deprotected with sodium methoxide in methanol, 
followed by hydrazinolysis to afford compound 11a (56 %) and 11b (35 %) over the two final steps 
[12]. (Scheme 2)  
 
 
Scheme 2- Synthesis of racemic compounds 11a and 11b. 
 
The biological activity of compound 11b as a pure enantiomer (3R,4R,5R) [13] is one order of 
magnitude less active than (±)-1-azafagomine relatively to -glucosidase (Ki = 3.0 M) and to -
glucosidase (Ki = 92.0 M), and 4 times less active than isomaltase (Ki = 4.0 M). Compound 11a 
shows a much lower activity than (±)-1-azafagomine. (See Table 1)  
 
To investigate the role of the hydroxyl groups in the binding to the enzyme and find if other groups 
could successfully substitute the hydroxyl groups, fluoride, amino, and hydrazine were introduced at 
position 3. Fluorine is a bioisostere of the hydroxy group with similar polarity and shape [14].
 
The 
amino group was introduced because it strongly enhanced the activity of neuraminic acid derivatives 
on neuraminidase and the same trend could happen with 1-azafagomine derivatives relatively to 
glycosidases [15]. 
The hydroxy group at C-3 in compound 1 was displaced with fluorine by using the synthetic 
intermediate epoxide 5. Reaction of compound 5 with HF and pyridine furnished a fluorinated 
compound, which was peracetylated to promote isolation giving compound 12 in 68 % yield. 
Deacetylation of 12 with sodium methoxide followed by hydrazinolysis yield compound 13 (28 %) 
together with compound 14 (50 %) as by-product. It had been demonstrated that the fluorine work as a 
leaving group under hydrazinolysis conditions, giving back the epoxide then opening again with 
hydrazine. (Scheme 3) 
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The amino group at the position 3 was introduced by opening the epoxide with trimethylsilylazide 
followed by reduction of the azido group and hydrazinolysis of the urazol moiety. Compound 15 was 
obtained in 69 % yield after the 3 steps. [16, 17](Scheme 3) 
 
 
 
Scheme 3- Synthesis of 3-fluoro-, 3-hydrazinyl-, and 3-amino-1-azafagomines. 
 
Displacement of the primary hydroxyl group in compound 5 with fluorine was carried out with 
diethylaminosulfur trifluoride (DAST). This reagent is known to be a powerful reagent for direct 
displacement of 6-hydroxyl group for fluorine in unprotected glucosides. The fluorine compound, 16, 
was obtained with 70 % yield. The epoxide hydrolysis occurs under aqueous perchloric acid and is 
followed by hydrazynolysis with defluorination to give compound 17 as the only product formed in 
27 % yield from 16. [17] (Scheme 4) 
 
 
Scheme 4- Attempt to substitute the hydroxymethyl group for fluoromethyl of 1-azafagomine. 
 
Compound 13 as is shown in the table 1 is poor inhibitor of both the - and -glucosidases which 
suggests that the hydroxy group binds in the enzyme as a proton donor rather than a proton acceptor, 
which of course the fluoride atom has no ability to do. The substitution of the hydroxyl group for the 
amino group (compound 15) has shown a diminution of activity either to - and -glucosidases.  The 
authors also concluded that the exocyclic amino group do not act as a hydrogen acceptor and its 
hydrogen donor ability is not affected by protonation. As happen with 3-amino-isofagomine [16] the 
amino group is acting as a poor hydrogen-bond donor compared to the hydroxyl group at the same 
 7 
position. Comparing 15 to the fluoro analogue 13 to which no hydrogen bond donor effect can be 
described it seems that the inhibitory potential of compound 15 is between the excellent hydrogen bond 
donor ability of compound 1 and the poor effect displayed by compound 13. 
 
 
Table 1: Inhibition constants (Ki) in M of various enzymes on target compounds measured at 25 ºC. 
 
 
Enzyme 
    
    
-glucosidase 
(yeast, pH 6.8) 
3.9 2.5 86 > 1000 > 1000 > 1000 340 3600 (11a) 
92 (11b) 
-glucosidase 
(almonds, pH 6.8) 
0.65 47 0.11 137 41 78.8 46 540 (11a) 
3 (11b) 
-glucosidase 
(almonds, pH 5.0)
0.76 330 --- --- --- ---  --- 
-glucosidase 
(almonds, pH 7.5)
1.09 --- --- --- --- ---  --- 
Isomaltase (baker´s 
yeast, pH 6.8) 
1.06 11 7.2 3080 > 3000 --- 95 690 (11a) 
4 (11b) 
-galactosidase  
(E. coli. pH 6.8) 
934 > 1000 --- --- --- ---  --- 
-galactosidase  
(E. coli. pH 6.8) 
702 > 1000 --- 149 > 1000 ---  --- 
-mannosidase  
(jack bean pH 5.0)
3306 270  
(pH 4.5) 
770  
(pH 4.5) 
323 185 ---  --- 
Phosphorylase A 13.5 
(IC50) 
55000 --- --- --- ---  --- 
 
 
2.2 Synthesis of fused bicyclic azafagomine analogues (castanospermine analogues)  
 
Two epimers of 5-aza-6-deoxycastanospermine analogues were obtained through Diels-Alder 
cycloaddition in the first step, from 5-benzyloxy-7-acetoxyhepta-1,3-diene 18 and PTAD [18]. 
(Scheme 5) 
 
 
Scheme 5- Cycloaddition of the diene 18 to PTAD. 
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Each of the epimeric adducts ()-19 and ()-20 underwent functional group transformations to give the 
azacastanospernine analogues. Scheme 6, briefly summarizes the synthetic sequence of one of the 
epimers, compound ()-26.  
Compound ()-19 was subjected to epoxidation followed by ring opening in the presence of 
trifluoroboro etherate, and acetic anhydride / acetic acid. The anti relationship of the acetyl groups was 
obtained, as expected. The acetyl groups were removed in compound 21 with sodium 
metoxide/methanol. Oxidation with TEMPO and sodium hypochlorite gave δ–lactone 22. Reduction 
with diisobutylaluminium hydride, followed by acetylation with acetic anhydride in the presence of 
triethyamine and 4-dimethylaminopyridine afforded compound 23. Treatment of 23 with benzylic 
alcohol in the presence of trifluoroboro etherate gave the acetal 24. This compound was deacetylated 
and then treated with hydrazine to give 25. Hydrogenolysis under Pd/C in methanol cleaved the benzyl 
groups and turn the aldehyde function free to suffer a reductive amination forming 5-aza-6-
deoxycastanospermine 26. (Scheme 6) 
 
 
 
Scheme 6- Formation of 5-aza-6-deoxycastanospermine analogue 26. 
 
Compound ()-21 was subjected to deacetylation with sodium metoxide, followed by hydrazinolysis to 
yield the triol 27.  The unprotected monocyclic 28 was obtained by hydrogenation under Pd in the 
presence of HCl. (Scheme 7) The same sequence was applied to the product obtained from compound 
()-20: epoxidation followed by epoxide opening in the presence of trifluoroboro etherate, under acetic 
anhydride / acetic acid to yield the respective diastereomer 29. (See Table 2) 
 
 
 
Scheme 7- Synthesis of monocyclic compound 28. 
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Epimer 26 showed a poor -glucosidase inhibition to the yeast source (Ki >600 M) and a much better 
inhibition to -glucosidase from rice (Ki= 15 M). The values for -glucosidase obtained from 
almonds are also good (Ki= 10 M). Even so the best result of castanospermine is for -glucosidase 
from rice (Ki= 0.015 M), three orders of magnitude more active than 26 for the same enzyme. The 
epimer of 26, 30 having the hydroxyl group of the five-membered ring at the equatorial position 
showed poorer values to the same enzymes: between Ki= 570 – 690 M, except for -glucosidase from 
rice to which the value is even poorer Ki >1000 M.  This strongly suggests a clear preference of 
glucosidases for binding substrates with the hydroxy group at the axial position [18]. (Figure 5) 
 
 
 
Figure 5- Haworth representations of 5-aza-6-deoxy castanospermine analogues. 
 
The best results obtained for compounds 29 and 30 goes for α-glucosidases either from rice and yeast, 
even so the Ki are between 150 and 380 μM. 
 
Table 2: Inhibition constants (Ki) in M of target compounds with various enzymes, 
measured at 25 ºC and pH 6.8, unless noted otherwise. 
 
Compound -glucosidase 
(yeast) 
-glucosidase 
(rice)
Isomaltase 
(yeast) 
-glucosidase 
(almonds) 
 
 
25 
 
0.01 (pH not given) 
 
11 
 
47 
 
 
> 1500 
 
0.015 (pH not given) 
 
--- 
 
1.5 (pH 5.0) 
 
 
2.0 
 
6 
 
0.27 
 
0.33 
 
 
> 600 
 
 
15 
 
79 
 
10 
 
 
570 
 
> 1000 
 
550 
 
690 
 
 
275 
 
250 
 
> 1000 
 
660 
 
 
380 
 
150 
 
> 1000 
 
820 
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3. Chiral 1-azafagomines, derivatives, and analogues 
 
3.1 Chemoenzymatic resolution of 1-azafagomine, and analogues 
Racemic 1-azafagomine described in scheme 1 was submitted to biocatalytic kinetic resolution using 
lipases [19]. An array of lipases was screened with poor results. Literature [20,21] refers a considerable 
number of reports using lipases for hydroxymethyl piperidines resolution; in all cases a less bulky 
group was attached at the nitrogen atom.  And so, a parallel cycloaddition using 4-methyl-1,2,4-
triazole-3,5-dione (MTAD), instead of PTAD, prepared in situ from methyl urazol and tert-butyl 
hypochlorite, was used as dienophile. The procedure gave cycloadduct 31 in 87 % yield. (Scheme 8) 
 
 
 
Scheme 8- Synthesis of cycloadduct 31. 
 
Lipase-catalysed transesterification of compound 31 used vinyl acetate as the acetyl donor. Two 
enzymes out of over 20 were selected: Candida antartica lipase showed a good conversion but low 
selectivity; the best selectivity was achieved from lipase R (obtained from Penicillium roqueforti) after 
17 h (12 % conversion, 96 % ee). The scale-up of the reaction with lipase R turned the process to be 
much slower, being stopped after ca 40 % conversion. This provides compound (S)-32 in 38 % yield 
and 86 % ee and (R)-31 in 60 % yield and 59 % ee [18]. (Scheme 9) The enantiopurity of the 
enantiomer (S)-32 could not be improved by crystallization, but after saponification of (S)-32, (S)-31 
was obtained in enantiopure form. Unreacted compound 31, from the crude enzyme esterification, was 
enantiomerically enriched in the (R)-alcohol. The sample was treated with Candida antartica lipase, 
which having a lower selectivity than lipase R, had a greater reaction rate. After 50 % conversion, 
48 % of the starting material was (R)-31, isolated with 99 % ee. The resolved alcohols were submitted 
to chemical group transformation. First, the epoxide was formed as a mixture of isomers: the 
compound with the anti disposition of the epoxide/hydroxymethyl group was the major product formed 
in 68 % (the minor isomer was isolated in 13 % yield). After, the epoxide was hydrolyzed to give the 
triol, and at last it was submitted to hydrazinolysis to give (-)-1 from (S)-31 and (+)-1 from (R)-31 [19].   
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Scheme 9- Lipase-catalysed transesterification of racemic cycloadduct 31. 
 
This strategy has an overall yield of 18 % after 5 steps, 9 % yield to each enantiomer. The optical 
purity of the compounds 31 was carried out by means of esterification of the alcohols (-)-31 and (+)-31 
with camphanoyl chloride in the presence of dimethylaminopyridine and triethylamine. The two 
diastereomeric forms differ substantially from one another in their 
1
H NMR spectra. 
 
1-Azagalactofagomine was synthetized from achiral 2,4-pentadien-1-ol (2) and MTAD by Diels-Alder 
cycloaddition followed by enzymatic resolution with lipase R as the key steps of the strategy to give 
compounds (S)-31 and (R)-31 [22]. Compound (S)-31 underwent epoxidation with m-
chloroperoxybenzoic acid at 80 ºC for 18 h affording a mixture of epoxides 33 and 34 in a 2:1 ratio, 
from which the major syn epoxide 33 was isolated in 42 % yield, and then opened with 57 % aqueous 
HI in acetic acid followed by in situ peracetylation with acetic anhydride to afford a mixture of 
acetylated iodides 35 and 36 in a 1 (35) : 3 (36) ratio and 75 % yield. The preference for the formation 
of 36 could be explained by geometrical constraints in the bicyclic system that are in favour of 3R,4R-
diaxial opening. The mixture of acetates 35 and 36 was treated with silver acetate in 6 % aqueous 
acetic acid and further acetylated with acetic anhydride and triethylamine affording a mixture of 
acetates 7 (37) : 3 (38) ratio. The formation of 37 as the major isomer was a drawback of this reaction. 
This was suppressed by using silver trifluoroacetate in 6 % aqueous trifluoroacetic acid. The 
stereoselectivity was improved to 96 (38) : 4 (37) in 79 % yield. Compound 38 contaminated with 4 % 
of 37 was reacted with sodium methoxide in methanol followed by treatment with hydrazine hydrate at 
100 ºC to give 1-azagalactofagomine 39 in 56 % yield for the last two steps [22]. (Scheme 10)  
 
 
 
Scheme 10 - Synthesis of 1-Azagalactofagomine. 
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Azagalactofagomine 39 was tested against a series of glycosidases. Not surprisingly compound 39 is a 
poor α-glucosidase inhibitor, but in contrast is a strong β-glucosidase and β-galactosidase inhibitor of 
several sources, together with -galactosidase from green coffee beans. It is noteworthy that compound 
39 is a slightly weaker inhibitor of β-galactosidase and β-glucosidase than is isogalactofagomine, but 
more potent than galactodeoxynojirimycine. In contrast, compound 39 is a stronger α-galactosidase 
inhibitor than isogalactofagomine, but weaker than galactodeoxynojirimycine. 
 
Table 3: Inhibition constants (Ki) in M of target compounds to various enzymes, 
measured at 25 ºC and pH 6.8. 
 
 
Enzyme 
  
 
-glucosidase (baker´s 
yeast) 
570 > 2000 (IC50) --- 
-glucosidase (almonds) 0.13 0.097 540 
-galactosidase (Aspergillus 
oryzae) 
0.04 0.004 --- 
-galactosidase (E. coli.) 0.30 0.2 (racemate measure) 12.5 
-galactosidase 
(Saccharomyces fragilis) 
7.8 0.33 81 
-galactosidase (green 
coffee beans) 
0.28 50 0.0016 
 
3.2 Synthesis of homochiral 1-azafagomine, derivatives, and analogues 
 
Most of the reported synthesis of azasugars has carbohydrates, amino acids and tartaric acid as starting 
materials [23-25]. E.g. (-)-1-Azafagomine and (+)-1-azafagomine have also been prepared from L- and 
D-xylose respectively [26]. More recently the Diels-Alder cycloaddition as the key synthetic step, has 
been appealing to several authors. Combining Stoodleys’s cycloaddition of (E)-1-(2',3',4',6'-tetra-O-
acetyl-β-D-glucopyranosyloxy)-1,3-butadiene 40 to PTAD with Bols’s olefin functionalization of the 
six-membered-ring and cleavage of the urazol moiety was obtained homochiral (-)-1-azafagomine. 
Cycloadduct 41 was prepared first in 70 % yield and in a high degree of diastereoselectivity. 
Treatement of 41 with triethylsilane in trifluoroacetic acid according to Stoodley’s protocol generated 
(-)-42 [27,28]. Epoxidation of compound (-)-42 with oxone/trifluoroacetone in the presence of sodium 
carbonate formed a 3:1 ratio of oxiranes, from which the major isomer 43 was crystallised. The 
epoxide moiety has an anti relationship to the ester group and was obtained in 65 % yield. The epoxide 
43 was opened in refluxing aqueous sulfuric acid with total regio- and stereo-selectivity to afford the 
trans-diol 44. On the other hand, osmilation of compound 42 produced the cis-diol 45 with total stereo-
selectivity. Selective reduction of trans-diol 44 and cis-diol 45 with sodium borohydride gave 
compounds 46 and 47, respectively. Reflux of these compounds with hydrazine hydrate gave the target 
compounds (-)-1-azafagomine (-)-1 in 14 % overall yield and (+)-5-epi-1-azafagomine (+)-48 in 26 % 
overall yield, from alkene (-)-42. (Scheme 11)  
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Scheme 11- Diastereoselective synthesis of 1-Azafagomine (-)-1 and 5-epi-1-azafagomine (+)-48. 
 
It is known that 2-N-alkyl-1-azafagomines are poorer glycosidase inhibitors than 1-azafagomine [29], 
but 1-N-alkylated compounds display a higher inhibitory potential together with a largely enhanced 
 electivity [30]. A series of 1-N-alkylated 1-azafagomines has been prepared to study the 
structure−activity relationship as glycosidase inhibitors. Scheme 12 represents the reaction sequence to 
obtain these compounds. An intermediate in the synthesis of 1-azafagomine from L-xylose, compound 
49 was used as starting material. Alkylation occurs readily at N-2 because this atom is more basic, 
using compound 49 as the starting material the problem is avoided [12]. Alternatively, 1-azafagomine 
could be directly acetylated with acetic anhydride in methanol giving a 4:1 ratio of 1-N- versus 2-N-
acetyl regio-isomers [17]. After separation the major compound 1-N-acetyl could be used as the 
starting material for the 2-N-alkylation. The introduction of the alkyl group at N-2 was tried by direct 
alkylation with e.g. alkyl halides but the reactions failed due to the low basicity of this nitrogen atom. 
Alkylation occurs by reductive amination with an aldehyde in the presence of Pd (II). Under these 
conditions the benzyl groups were simultaneously cleaved to afford compounds 50. The acetyl group 
was removed by ion-exchange acidic resine and compounds 51 were obtained in good yields. (Scheme 
12) 
 
 
 
 
Scheme 12- Synthesis of 2-N-alkylated 1-azafagomines. 
 
Compounds 51 were investigated for inhibition of -glucosidase from yeast source and -glucosidase 
N
NH
BnO
BnO
OBn
49
Ac
RCHO, H2, Pd(OH)2
AcOH, EtOAc-H2O
N
N
HO
HO
OH
Ac
R
R= butyl, 70 %
      hexyl, 82 %
      heptyl, 54 %
      nonyl, 60 %
      decyl, 35 %
      3-phenylpropyl, 51 %
1. 6M HCl, reflux, 18 h
2. Amberlite IR-120 (H+),
1M aq. NH3
50,
NH
N
HO
HO
OH
R
51a, R= butyl, 95 %
51b, R= hexyl, 68 %
51c, R=  heptyl, 86 %
51d, R= nonyl, 99 %
51e, R= decyl, 50 %
51f, R= 3-phenylpropyl, 90  %
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from almonds. All compounds showed to be competitive inhibitors and the Ki were determined. The 
inhibition of -glucosidase was 10-30 times weaker than 1-azafagomine, showing that a free nitrogen 
atom at N-2 is important for the enzyme-substrate interaction. On the other hand, all compounds 51 
revealed a much better activity against -glucosidase than 1-azafagomine. The N-hexyl (51b) and the 
N-(3-phenypropyl) (51f) are the preeminent compounds with five- to tenfold increased binding to β-
glucosidase enzymes relatively to 1-azafagomine. (See Table 4) 
 
A new homochiral derivative of 1-azafagomine, 2-N-phenyl carboxamide hexahydropyridazine (-)-52 
was obtained from the intermediate (-)-42 [31]. (Scheme 11) Treatment of compound (-)-42 with 
freshly opened LiAlH4 (15 eq.) selectively reduced one of the carbonyl groups of the 
phenyltriazolidinone moiety to afford compound (-)-52. (Scheme 13) The synthesis of its enantiomer, 
compound (+)-52, was obtained from 41 by epimerization of H-5 inducted with NEt3 and p-
chlorothiophenol to give compound 53. (Scheme 13) The glucosyl moiety was removed afterwards 
with triethylsilane in trifluoroacetic acid to yield (+)-42 in 84 %. The reactive sequence followed the 
same route of the levorotatory isomer (-)-42 being obtained (+)-2-N-phenyl carboxamide 
hexahydropyridazine (+)-52 from enantiomer (+)-42. (Scheme 13) Compounds (-)-2-N-phenyl 
carboxamide hexahydropyridazine (-)-52 and (+)-2-N-phenyl carboxamide hexahydropyridazine (+)-52 
were obtained in 29 % and 10 % overall yield, starting from compounds 41 and 53 respectively.  
 
 
 
Scheme 13- Synthesis of (-)- and (+)-2-N-carboxamide hexahydropyridazines. 
 
Both enantiomers (-)-52 and (+)-52 were tested against yeast - -
glucosidase. Curiously the -glucosidase inhibition of compound (-)-52 display a Ki = 3.36 M and 
(+)-52 a relatively similar result Ki = 10.6 M, in strict contradiction with the results of -glucosidase 
inhibition in the (-)-2-N-alkyl hexahydropyridazine derivatives. Another curious achievement is the 
question raised against the established knowledge that there is a big difference between the left- and 
dextrorotatory enantiomers in respect to the inhibition activity. In this case it just do not apply. It was 
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found in the past that the dextrorotatory 1-azafagomine was practically inactive towards α- and -
glucosidases [26]. The relationship of inhibition activities between the two enantiomers (-)-52 and (+)-
52 is ca 1:3, in favour of levorotatory isomer relatively to -glucosidase from backer’s yeast source, 
ca 1:2 relatively to -glucosidase from almonds. The interaction of both enantiomers (-)-52 and 
(+)-52 with -glucosidase was studied by molecular modelling. The aromatic ring seems to efficiently 
pack into a hydrophobic pocket in the enzyme’s active site, which could be responsible for the 
improved binding affinity of these compounds in relation to underivatized (-)-1-azafagomine and (+)-1-
azafagomine [31]. 
 
 
Reaction of optically active compound 34 with HI in acetic acid gave a single iodinated product 54, 
with the attack occurring at the more accessible carbon atom. The product 54 was obtained with 73 % 
yield. This iodide was subjected to radical reduction with tribuylstannane-azobisisobutyronitrile 
(Bu3SnH-AIBN) to give the 4-deoxy derivative 55 in 65 % yield. Deacetylation with sodium 
methoxide in methanol followed by hydrazinolysis gave compound 56 in 57 % yield. The diastereomer 
of compound 34, epoxide 33 under HI in acetic acid followed by treatment with acetic anhydride yield 
two regio-isomers: compounds 35 and 36. These were subjected to the reductive conditions to which 
compound 54 was submitted, giving a mixture of compounds 57 and 58. The mixture was separated to 
give 58 in 46 % yield and 57 in 21 % yield. After deacetylation and hydrazinolysis the deoxy- 
compounds 59 and 60 were obtained in 65 % and 63 % yield, respectively [13]. (Scheme 14) 
 
 
 
Scheme 14- Synthesis of deoxyazasugars 56, 59 and 60. 
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Table 4: Inhibition constants (Ki) in M of target compounds with various enzymes, 
measured at 25 ºC and pH 6.8, unless noted otherwise. 
 
Compound -glucosidase 
(backer´s yeast) 
-glucosidase 
(almonds) 
/ selectivity 
 
 
6.90 (pH 6.8) 
 
0.32 (pH 6.8) 
 
22 
 
 
158 (pH 6.8) 
 
0.032 (pH 6.8) 
 
4938 
 
 
278 (pH 6.8) 
 
0.55 (pH 6.8) 
 
5054 
 
 
3.36 (pH 7.0) 
--- (pH 5.0) 
 
14.7 (pH 7.0) 
67.4 (pH 5.0) 
 
0.23 
 
 
10.6 (pH 7.0) 
--- (pH 5.0) enzyme inactive 
 
25.2 (pH 7.0) 
90.0 (pH 5.0) 
 
0.42 
 
 
1-Azagulofagomine analogue 61 was obtained in a 5 steps strategy with 25 % overall yield [32]. The 
key step is an asymmetric hetero Diels-Alder cycloaddition of chiral 1-p-tolylsulfinyl-1,3-pentadiene 
62 to MTAD (Scheme 15). The reaction occurs at -10 ºC generating cycloadduct 63, which underwent 
a [2,3] sigmatropic rearrangement of the sulfinyl group leading to compound 64. Compound 64 was 
treated with trimethylphosphite as a thiophilic agent to form the alcohol 65 in 98 % yield and 91 % ee 
[33]. Compound 65 was silylated with 
t-
butyldimethylsilyl triflate in presence of triethylamine to give 
the derivative 66. Oxidation of the double bond with osmium tetroxide and N-methylmorpholine oxide 
gave a mixture of cis diols in a ratio 9:1 and 80 % de, from which the major isomer 67 was isolated in 
46 %. Surprisingly the same compound 67, but in better yield and higher de (64 % yield, 98 % de) was 
obtained by epoxidation of the double bond with 3-methyl-3-trifluoromethyldioxirane followed by 
hydrolysis under basic conditions.  
 
(-)-1
NH
NHHO
HO
OH
(-)-51fNH
NHO
HO
OH
(CH2)3Ph
(-)-51bNH
NHO
HO
OH
(CH2)5CH3
(-)-52
NH
N
HN
O
Ph
HO
HO
OH
(+)-52
NH
N
HN
O
Ph
HO
HO
OH
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Scheme 15- Formation of 1-azagulofagomine analogue 61. 
 
Although hydrazine has been used to cleave N-methyl urazole units in several compounds of type 67 
[19,34], it did not work in compound 67. To overcome this problem, the two vicinal hydroxyl groups 
of diol 67 were protected as an acetal to form 68, which was then treated with NH2NH2 to give a 1-
azagulofagomine analogue 61 in quantitative yield. (Scheme 15) 
An explanation for the unexpected result obtained in the epoxide opening was suggested to be an 
assisted opening by a lone pair of electrons of the oxygen in the OTBS group, that would occur before 
the nucleophilic attack promoted by the hydroxide anion, according to figure 6. 
 
 
 
Figure 6- Assistance of the OTBS group in the epoxide opening leading to cis diol 70. 
 
No glycosidase inhibition study was found for compound 64. 
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